Co-D Therapeutics, Inc.


BiotechProfiles™ is the premier resource for jobs, company information, professional networking and productivity tools in the Madison, Wisconsin biotechnology and medical device industry. Recognized as one of the premier emerging biotechnology clusters in the U.S., this robust industry sector comprises nearly 10,000 employees in approximately 150 companies. BiotechProfiles also maintains a unique directory of the largest 250 pharmaceutical companies worldwide, including business development contacts whenever available. This tool is indispensable for executives pursuing strategic alliances and technology licenses.
Designed as a suite of easy to use, searchable databases that are continually updated, BiotechProfiles serves the needs of biotech business development and operational executives in early stage companies, as well as the general public. With these tools you can quickly bypass the data collection and screening stage and immediately focus on solving your strategic partnering or operational needs. We've assembled your background data for you!
  Next »

BiotechProfiles is also the premier site for data on Biotechnology Companies in Madison Wisconsin, Biotechnology Jobs in Madison Wisconsin

Biotechnology Companies in Madison Wisconsin; Biotechnology Jobs in Madison Wisconsin
  « Previous | Next »

Biotechnology Business Development, Partnering and Strategic Alliances

Biotechnology Business Development, Partnering and Strategic Alliances
  « Previous | Next »

Madison Biotechnology Companies; Madison Biotechnology Jobs

Madison Biotechnology Companies; Madison Biotechnology Jobs
  « Previous | Next »

List or rank of Largest Pharmaceutical Companies Worldwide

List of rank of Largest Pharmaceutical Companies Worldwide
  « Previous


Company Profile

Co-D Therapeutics, Inc. based in Madison, WI, is an innovative drug development company dedicated to bringing to market first-in-class, combination nano-medicines with high safety profiles to treat cancer and improve patients’ lives.

Co-D Therapeutics’ polymeric platform technology focuses on the formulation and delivery of multiple anticancer agents in a single novel therapeutic.

Co-D Therapeutics is developing its nano-medicine lead product, Triolimus, to treat the rare malignancy, angiosarcoma, under an orphan drug designation, breast cancer and non-small cell lung cancer. Triolimus will replace less efficacious, less safe, and more complex conventional combination chemotherapy regimens in clinical practice.
Business Sectors
Pharmaceuticals Human Diagnostics  
Med or Lab Devices   Lab Reagents or Services  
Drug Manufacturing   Food & Agribusiness  
CRO   Bioinformatics or Software  
Company History
Co-D Therapeutics, Inc.
Address 1625 Kings Mill Way
[Map] Madison
Phone 608-358-9655
Website Link
Head Abdalla A. Saad
Company Statistics
Global Headcount 3
Local Headcount 3
Year Founded 2012
Ownership Private
Stock Exchange

Parent Company
Divisional Level
Senior Level
Global Headcount
Stock Exchange
Reference Documents
Corporate Profile
2013 - Co-D Therapeutics Executive Summary [View]
2016 - Co-D Therapeutics Advances 3-in-1 Cancer Drug [View]